HUE045395T2 - Stabilizált dezmopresszin - Google Patents

Stabilizált dezmopresszin

Info

Publication number
HUE045395T2
HUE045395T2 HUE15734080A HUE15734080A HUE045395T2 HU E045395 T2 HUE045395 T2 HU E045395T2 HU E15734080 A HUE15734080 A HU E15734080A HU E15734080 A HUE15734080 A HU E15734080A HU E045395 T2 HUE045395 T2 HU E045395T2
Authority
HU
Hungary
Prior art keywords
desmopressin
stabilized
stabilized desmopressin
Prior art date
Application number
HUE15734080A
Other languages
English (en)
Hungarian (hu)
Inventor
Bong Sang Lee
Su-Jun Park
Jiyeong Han
Myeongcheol Kil
Min Seop Kim
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53510836&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE045395(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of HUE045395T2 publication Critical patent/HUE045395T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HUE15734080A 2014-06-16 2015-06-15 Stabilizált dezmopresszin HUE045395T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020140073067A KR20150144209A (ko) 2014-06-16 2014-06-16 안정화된 데스모프레신 또는 이의 약학적으로 허용가능한 염을 함유 약학 조성물

Publications (1)

Publication Number Publication Date
HUE045395T2 true HUE045395T2 (hu) 2019-12-30

Family

ID=53510836

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE15734080A HUE045395T2 (hu) 2014-06-16 2015-06-15 Stabilizált dezmopresszin

Country Status (33)

Country Link
US (1) US20170128521A1 (cg-RX-API-DMAC10.html)
EP (1) EP3154516B1 (cg-RX-API-DMAC10.html)
JP (1) JP6615130B2 (cg-RX-API-DMAC10.html)
KR (2) KR20150144209A (cg-RX-API-DMAC10.html)
CN (1) CN106456706B (cg-RX-API-DMAC10.html)
AR (1) AR100850A1 (cg-RX-API-DMAC10.html)
AU (1) AU2015276247C1 (cg-RX-API-DMAC10.html)
CA (1) CA2951768C (cg-RX-API-DMAC10.html)
CL (1) CL2016003219A1 (cg-RX-API-DMAC10.html)
CO (1) CO2017000354A2 (cg-RX-API-DMAC10.html)
DK (1) DK3154516T3 (cg-RX-API-DMAC10.html)
EA (1) EA032834B1 (cg-RX-API-DMAC10.html)
ES (1) ES2751600T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20191746T1 (cg-RX-API-DMAC10.html)
HU (1) HUE045395T2 (cg-RX-API-DMAC10.html)
IL (1) IL249538A0 (cg-RX-API-DMAC10.html)
JO (1) JO3500B1 (cg-RX-API-DMAC10.html)
LT (1) LT3154516T (cg-RX-API-DMAC10.html)
MX (1) MX374540B (cg-RX-API-DMAC10.html)
MY (1) MY182781A (cg-RX-API-DMAC10.html)
NZ (1) NZ727388A (cg-RX-API-DMAC10.html)
PH (1) PH12016502527B1 (cg-RX-API-DMAC10.html)
PL (1) PL3154516T3 (cg-RX-API-DMAC10.html)
PT (1) PT3154516T (cg-RX-API-DMAC10.html)
RS (1) RS59449B1 (cg-RX-API-DMAC10.html)
SA (1) SA516380492B1 (cg-RX-API-DMAC10.html)
SG (2) SG10201811139UA (cg-RX-API-DMAC10.html)
SI (1) SI3154516T1 (cg-RX-API-DMAC10.html)
TN (1) TN2016000561A1 (cg-RX-API-DMAC10.html)
TW (1) TWI670070B (cg-RX-API-DMAC10.html)
UA (1) UA119776C2 (cg-RX-API-DMAC10.html)
WO (1) WO2015193246A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201608020B (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114432424B (zh) * 2021-12-27 2023-06-27 南通联亚药业股份有限公司 一种稳定的铝塑包装去氨加压素片剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
DE60307082D1 (de) * 2002-05-07 2006-09-07 Ferring Bv In der mundhöhle dispergierbare phamarzeutische zusammensetzung mit desmopressin
WO2007083323A2 (en) * 2006-01-23 2007-07-26 Panacea Biotec Limited. Modified release oral dosage form comprising desmopressin
CN100463674C (zh) * 2006-12-22 2009-02-25 江苏奥赛康药业有限公司 一种氯雷他定口腔速溶膜及其制备方法
US20150306170A1 (en) * 2012-11-21 2015-10-29 Ferring B.V. Composition for immediate and extended release
TW201422254A (zh) * 2012-11-21 2014-06-16 Ferring Bv 用於速釋及延釋的組成物

Also Published As

Publication number Publication date
BR112016029417A2 (pt) 2017-08-22
HRP20191746T1 (hr) 2019-12-27
JP2017523955A (ja) 2017-08-24
WO2015193246A1 (en) 2015-12-23
US20170128521A1 (en) 2017-05-11
KR20170020450A (ko) 2017-02-22
RS59449B1 (sr) 2019-11-29
DK3154516T3 (da) 2019-09-23
TWI670070B (zh) 2019-09-01
AU2015276247B2 (en) 2019-09-12
EA201692556A1 (ru) 2017-04-28
PH12016502527A1 (en) 2017-04-10
NZ727388A (en) 2021-07-30
PL3154516T3 (pl) 2020-08-10
CN106456706B (zh) 2020-07-14
AR100850A1 (es) 2016-11-02
SA516380492B1 (ar) 2021-02-03
TN2016000561A1 (en) 2018-04-04
JO3500B1 (ar) 2020-07-05
KR20150144209A (ko) 2015-12-24
ZA201608020B (en) 2020-05-27
JP6615130B2 (ja) 2019-12-04
KR102360656B1 (ko) 2022-02-09
CA2951768A1 (en) 2015-12-23
EP3154516B1 (en) 2019-09-04
SI3154516T1 (sl) 2019-11-29
CL2016003219A1 (es) 2017-06-30
MX374540B (es) 2025-03-06
PH12016502527B1 (en) 2017-04-10
SG10201811139UA (en) 2019-01-30
ES2751600T3 (es) 2020-04-01
UA119776C2 (uk) 2019-08-12
IL249538A0 (en) 2017-02-28
MY182781A (en) 2021-02-05
CO2017000354A2 (es) 2017-03-31
EP3154516A1 (en) 2017-04-19
CN106456706A (zh) 2017-02-22
SG11201609374YA (en) 2017-01-27
AU2015276247C1 (en) 2020-02-06
MX2016016635A (es) 2017-06-06
LT3154516T (lt) 2019-10-25
EA032834B1 (ru) 2019-07-31
PT3154516T (pt) 2019-12-05
CA2951768C (en) 2022-08-30
BR112016029417A8 (pt) 2021-06-29
TW201605464A (zh) 2016-02-16
AU2015276247A1 (en) 2017-02-02

Similar Documents

Publication Publication Date Title
DK3237446T3 (en) Anti-PD-1-antistoffer
DK3373003T3 (en) Urinteststrimmel
IL239830B (en) Case
AU361515S (en) Dishrack
AU359704S (en) Case
GB201505423D0 (en) Not published
DK2982407T3 (en) Trinfuntion til styrbare føringstråde
PL3237349T3 (pl) Ulepszony biologiczny środek wiążący
DK3194944T3 (en) Tomografiapparat
GB201601286D0 (en) Multi-eptopic construct
GB201419494D0 (en) Variations
GB201401268D0 (en) TrackPack
GB201406378D0 (en) Turretflow
IL249538A0 (en) Desmopressin is stabilized
GB201403931D0 (en) Podoquick
DK3167324T3 (en) Modulært forbindelsessystem til telekommunikationsudstyr
AU5594P (en) Lanoregon Mandevilla sanderi
AU5585P (en) Lanutah Mandevilla sanderi
AU5591P (en) Lanmontana Mandevilla sanderi
GB201415450D0 (en) Case
AU2014265V (en) FlatdampGL Westringia dampieri
SG10201404628TA (en) Ball-bond arrangement
AU358508S (en) Bedhead
AP00670S1 (en) Legate
HU4401U (en) Panel-safety arrangement